Mark Berner-Hansen Selected Research

Neoplasms (Cancer)

6/2022	Correction: Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia.
5/2022	Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Berner-Hansen Research Topics

Disease

2	Short Bowel Syndrome 12/2022 - 01/2021
2	Neoplasms (Cancer) 06/2022 - 05/2022
1	Pain (Aches) 05/2023
1	Pancreatitis 05/2023
1	Disease Progression 05/2023
1	Body Weight (Weight, Body) 01/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Anastomotic Leak 01/2020

Drug/Important Bio-Agent (IBA)

2	Glucagon (Glukagon)FDA Link 12/2022 - 01/2021
2	EnzymesIBA 06/2022 - 05/2022
2	EicosanoidsIBA 06/2022 - 05/2022
1	naldemedineIBA 05/2023
1	Opioid Analgesics (Opioids)IBA 05/2023
1	Narcotic Antagonists (Opioid Antagonists)IBA 05/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2022
1	Dinoprostone (PGE2)FDA Link 05/2022
1	Lipoxygenase (Lipoxygenase-1)IBA 05/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	apraglutideIBA 01/2021
1	Glucagon-Like Peptide-2 ReceptorIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020